Source briefing
What ‘good luck’ means to a coal miner
Berlin artist explores labor, pride, and unsung heroes of Germany’s ‘economic miracle’ in Harvard exhibit
Read →
Source briefing
Chatbot attachment issues
When AI companions get a personality update, some users respond with grief, study finds
Read →Source briefing
Why John Coltrane still matters
Jazz experts, scholars detail how iconic saxophonist, who would have turned 100 this year, reshaped most American musical genre
Read →Source briefing
Multisectoral Emergence of Multidrug-Resistant Campylobacter coli Sequence Type 10042 Lineage, Europe, 2018–2025
M. Azevedo et al.
Read →
Source briefing
Human medicines European public assessment report (EPAR): Povofortay, povorcitinib, Status: Opinion
Human medicines European public assessment report (EPAR): Povofortay, povorcitinib, Status: Opinion
Read →Source briefing
Human medicines European public assessment report (EPAR): Zeydovio, glepaglutide, Status: Opinion
Human medicines European public assessment report (EPAR): Zeydovio, glepaglutide, Status: Opinion
Read →
Source briefing
Human medicines European public assessment report (EPAR): Sepalna, senaparib, Status: Opinion
Human medicines European public assessment report (EPAR): Sepalna, senaparib, Status: Opinion
Read →Source briefing
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 10, Status: Authorised
Read →